vimarsana.com
  1. Home
  2. Live Updates
  3. Richard Lepke - Breaking News

Latest Breaking News On - Richard lepke - Page 1 : vimarsana.com

Vir Biotechnology, Inc : Multiple Abstracts Highlighting Vir Biotechnology s Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024

- Company to present important new data from the Phase 2 SOLSTICE chronic hepatitis delta trial - - Conference call scheduled for June 5, 2024, at 6:00 a.m. ET 12:00 p.m. CEST - Vir Biotechnology

France generalSnehav guptaCarey hwangCarly scadutoAndrea cathcartRichard lepkeTarik asselahAlnylam pharmaceuticals incUniversity of parisClinical researchExchange commissionVir biotechnology incEuropean associationLiver diseasesSenior vice presidentInterim chief medical

Vir Biotechnology, Inc : Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the EASL Congress has changed the Company's Phase 2 SOLSTICE hepatitis delta presentation from a late-breaker poster to an oral presentation. The

Carly scadutoRichard lepkeAlnylam pharmaceuticals incExchange commissionVir biotechnology incCompany phaseVir biotechnologyEuropean associationLiver diseasesEnhanced stabilization chemistry plusAlnylam pharmaceuticalsPrivate securities litigation reform actExternal communicationsInvestor relationsIhr portfolio

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences

Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCarly scadutoRichard lepkeFontainebleau hotel in miami beachVir biotechnology incHealth care conferenceAnnual health care conferenceBoston marriott copley placeMarianne de backerChief executive officerPartners global biopharma conferenceFontainebleau hotelAnnual global healthcare conferenceLoews miami beach hotelVir biotechnologyMedia relations

Codex DNA, Inc (DNAY) Q1 2022 Earnings Call Transcript

DNAY earnings call for the period ending March 31, 2022.

United statesTodd nelsonSteven mah cowenPaul knight keybancSteven mahJennifer mcnealeyRichard lepkeBrandon couillard jefferiesPaul knightBrandon couillardCodex dna incCompany analystEton bioEton bioscienceBioxp kitsNorth america

Codex DNA, Inc (DNAY) Q4 2021 Earnings Call Transcript

DNAY earnings call for the period ending December 31, 2021.

Todd nelsonPaul knight keybancJennifer mcnealeyJen mcnealeyRichard lepkeBrandon couillard jefferiesDan gibsonPaul knightBrandon couillardGibson assemblyCodex dna incEton bioscienceBanc capital markets

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.